Page results
-
Information about psychological therapy services at the Royal London Hospital for Integrated Medicine.
-
The urology service at UCLH comprises six sub-specialist teams: adolescent urology, andrology, female reconstruction, male reconstruction, stones and uro-oncology. The majority of urology inpatient…
-
The Charles Dent Metabolic Unit (CDMU) is one of the largest and longest established services in the world for the treatment of adolescents and adults (aged 16 years and older) with inherited metabolic diseases.
-
This service is for travellers who have returned from the tropics within the last year who are recently unwell with conditions such as fever, bloody diarrhoea or rash.
-
The Neurogenetics Unit offers a fully integrated service encompassing clinical assessment, diagnosis, molecular genetic testing and counselling for neurogenetic conditions.
-
Pan-London Post-COVID service for children and young people
-
University College Hospital is one of only eight centres in London that has a Hyper-acute Stroke Unit or a HASU as they are known.
-
General cardiology outpatients for local patients are provided by University College Hospital. Specialist and interventional cardiology outpatient services are provided by Barts Heart Centre.
-
UCLH has a comprehensive service for the assessment and treatment of patients with pleural disease.
File results
-
FOI/2024/0372 - Contact details of e-learning department
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0386 - Stonewall funding for 2022/23-2023/24
-
FOI/2024/0391 - Hospital admissions due to psychedelics consumption
-
FOI/2024/0404 - Senior HR/ Workforce staff contact details
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine